To evaluate the prognostic value of the glucose-to-lymphocyte ratio in patients with surgically treated endometrial cancer.
Conducted a retrospective cohort study
Analyzed glucose-to-lymphocyte ratio in relation to outcomes
Assessed disease-free survival rates among participants
Found that the glucose-to-lymphocyte ratio is an independent prognostic factor for disease-free survival
Indicated that lower ratios correlate with better survival rates
Abstract
GLR is an independent prognostic factor for DFS in endometrial cancer and may serve as a readily available, cost-effective biomarker. Further prospective studies are needed for validation.
Perguntar à IA
Like
Bookmark
Share
View Full Paper
Perguntar à IA
Like
Bookmark
Share
View Full Paper
Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study | Synapse